| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 79.064 | 85.346 | 95.574 | 93.377 | 113.608 | 117.265 | 151.922 | 155.293 | 173.010 | 208.917 |
| Total Income - EUR | 81.233 | 86.408 | 96.686 | 99.445 | 113.723 | 117.367 | 154.426 | 162.337 | 176.112 | 210.115 |
| Total Expenses - EUR | 79.334 | 81.663 | 80.116 | 91.050 | 88.647 | 116.853 | 105.674 | 126.721 | 127.128 | 132.413 |
| Gross Profit/Loss - EUR | 1.899 | 4.745 | 16.570 | 8.395 | 25.076 | 514 | 48.753 | 35.616 | 48.983 | 77.702 |
| Net Profit/Loss - EUR | 298 | 3.881 | 14.550 | 7.401 | 24.076 | -113 | 47.553 | 34.362 | 47.618 | 71.559 |
| Employees | 4 | 5 | 4 | 3 | 3 | 3 | 5 | 4 | 5 | 5 |
Check the financial reports for the company - Amamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40.065 | 33.693 | 42.417 | 44.427 | 32.630 | 25.467 | 47.919 | 76.128 | 73.984 | 59.436 |
| Current Assets | 12.648 | 12.224 | 19.188 | 19.643 | 20.044 | 22.731 | 49.741 | 57.341 | 29.509 | 81.865 |
| Inventories | 2.681 | 732 | 1.722 | 2.634 | 1.878 | 3.426 | 5.093 | 10.672 | 7.662 | 5.836 |
| Receivables | 7.970 | 7.747 | 13.227 | 9.732 | 9.992 | 12.043 | 17.606 | 36.824 | 12.977 | 50.427 |
| Cash | 1.998 | 3.745 | 4.239 | 7.277 | 8.174 | 7.262 | 27.043 | 9.846 | 8.870 | 25.603 |
| Shareholders Funds | 32.515 | 14.185 | 28.495 | 35.373 | 34.361 | 26.415 | 55.302 | 42.134 | 53.605 | 74.606 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 20.808 | 31.732 | 33.109 | 28.697 | 18.313 | 21.115 | 39.841 | 87.939 | 48.794 | 65.691 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 668 | 2.518 | 3.396 | 1.329 | 1.026 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Amamed Srl